Efficient ADCC killing of meningioma by avelumab and a high-affinity natural killer cell line, haNK

Meningiomas are the most common adult primary tumor of the central nervous system, but there are no known effective medical therapies for recurrent meningioma, particularly for World Health Organization grade II and III tumors. Meningiomas arise from the meninges, located outside the blood-brain bar...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JCI Insight
Auteurs principaux: Giles, Amber J., Hao, Shuyu, Padget, Michelle, Song, Hua, Zhang, Wei, Lynes, John, Sanchez, Victoria, Liu, Yang, Jung, Jinkyu, Cao, Xiaoyu, Fujii, Rika, Jensen, Randy, Gillespie, David, Schlom, Jeffrey, Gilbert, Mark R., Nduom, Edjah K., Yang, Chunzhang, Lee, John H., Soon-Shiong, Patrick, Hodge, James W., Park, Deric M.
Format: Artigo
Langue:Inglês
Publié: American Society for Clinical Investigation 2019
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6824312/
https://ncbi.nlm.nih.gov/pubmed/31536478
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/jci.insight.130688
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires